// App-Quantinova.ai

OP0147 : TARGETED TREATMENT WITH COMBINATION DMARDS PRODUCES EXCELLENT CLINICAL AND RADIOGRAPHIC LONG-TERM OUTCOMES IN EARLY RHEUMATOID ARTHRITIS REGARDLESS OF INITIAL INFLIXIMAB. THE 5-YEAR FOLLOW-UP RESULTS OF THE NEO-RACO TRIAL

Researchers

Presenter

  • V. Rantalaiho

Principal Investigators

  • M. Korpela

  • P. Hannonen

  • O. Kaipiainen-Seppanen

  • T. Mottonen

  • M. Kauppi

  • A. Karjalainen

  • K. Laiho

  • H. Kautiainen

  • M. Leirisalo-Repo

Medical Centers

  • Helsinki University Hospital, Helsinki, Finland

Locations

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • Sulfasalazine

  • Methotrexate

  • Prednisolone

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved